Literature DB >> 17711877

Cell-surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1.

Evgeny A Zemskov1, Irina Mikhailenko, Dudley K Strickland, Alexey M Belkin.   

Abstract

Tissue transglutaminase functions as a protein crosslinking enzyme and an integrin-binding adhesion co-receptor for fibronectin on the cell surface. These activities of transglutaminase and the involvement of this protein in cell-matrix adhesion, integrin-mediated signaling, cell migration and matrix organization suggest a precise and efficient control of its cell-surface expression. We report a novel mechanism of regulation of surface transglutaminase through internalization and subsequent lysosomal degradation. Constitutive endocytosis of cell-surface transglutaminase depends on plasma membrane cholesterol and the activity of dynamin-2, and involves both clathrin-coated pits and lipid rafts or caveolae. Furthermore, the key matrix ligands of transglutaminase, fibronectin and platelet-derived growth factor, promote its endocytosis from the cell surface. Our results also indicate that transglutaminase interacts in vitro and on the cell surface with the major endocytic receptor, low-density lipoprotein receptor-related protein 1, and demonstrate the requirement for this receptor in the endocytosis of transglutaminase. Finally, a deficiency of this endocytic receptor or blockade of endo-lysosomal function upregulate transglutaminase expression on the cell surface, leading to increased cell adhesion and matrix crosslinking. These findings characterize a previously unknown pathway of transglutaminase internalization and degradation that might be crucial for regulation of its adhesive and signaling functions on the cell surface and reveal a novel functional link between cell-matrix adhesion and endocytosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17711877     DOI: 10.1242/jcs.010397

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  23 in total

1.  Transglutaminase 2 as a novel activator of LRP6/β-catenin signaling.

Authors:  S Deasey; D Nurminsky; S Shanmugasundaram; F Lima; M Nurminskaya
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

Review 2.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

Review 3.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

4.  The fate of internalized α5 integrin is regulated by matrix-capable fibronectin.

Authors:  Henry C Hsia; Mohan R Nair; Siobhan A Corbett
Journal:  J Surg Res       Date:  2014-06-04       Impact factor: 2.192

Review 5.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

6.  Giardia lamblia low-density lipoprotein receptor-related protein is involved in selective lipoprotein endocytosis and parasite replication.

Authors:  Maria R Rivero; Silvana L Miras; Rodrigo Quiroga; Andrea S Rópolo; Maria C Touz
Journal:  Mol Microbiol       Date:  2011-01-05       Impact factor: 3.501

7.  GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.

Authors:  Liquan Yang; Scott Friedland; Nancy Corson; Lei Xu
Journal:  Cancer Res       Date:  2013-12-19       Impact factor: 12.701

8.  Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes.

Authors:  Michele P Lambert; Yuhuan Wang; Khalil H Bdeir; Yvonne Nguyen; M Anna Kowalska; Mortimer Poncz
Journal:  Blood       Date:  2009-07-15       Impact factor: 22.113

9.  LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways.

Authors:  Benoit Langlois; Gwenn Perrot; Christophe Schneider; Patrick Henriet; Hervé Emonard; Laurent Martiny; Stéphane Dedieu
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

10.  Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase.

Authors:  Evgeny A Zemskov; Elena Loukinova; Irina Mikhailenko; Richard A Coleman; Dudley K Strickland; Alexey M Belkin
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.